Hematopoietic stem cell (HSC) transplantation therapy is used in the treatment of various blood disorders including leukemia, lymphoma, and sickle cell anemia. A recent review article published by Dr. Hari Maganti’s lab explores current advancements in pre-clinical research on the biology and mechanism of HSC homing and engraftment following transplantation.

The Specialization in Transfusion Science (STS) program is a new training program in development at the University of Alberta. Once launched, it will be the only program in Canada where medical laboratory technologists can develop advanced competencies in transfusion and earn credentials.